DBV Technologies (DBVT) Return on Invested Capital (2021 - 2026)
DBV Technologies (DBVT) reported Return on Invested Capital of 0.01% for Q1 2026, up 7.0% year-over-year from 0.01% in Q1 2025, and up 32.58% on a QoQ basis from 0.01% in Q4 2025.
DBV Technologies (DBVT) has 6 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Invested Capital rose 7.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 7.0% YoY) and the FY2025 annual result came in at 0.02%, changed 0.0% from the prior year.
- Return on Invested Capital improved to 0.01% in Q1 2026 per DBVT's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q3 2022 and bottomed at 0.08% in Q1 2025.
- The 5-year median for Return on Invested Capital is 0.01% (2026), against an average of 0.01%.
- The widest annual swing landed in 2025, when Return on Invested Capital dropped 7 bps; it then advanced 7 bps in 2026.
- Tracing DBVT's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then decreased by 13 bps to 0.01% in 2023, then sank by 433 bps to 0.03% in 2024, then jumped by 54 bps to 0.01% in 2025, then jumped by 33 bps to 0.01% in 2026.
- Per Business Quant, the three latest DBVT Return on Invested Capital figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.01% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |